Buscar
Mostrando ítems 41-50 de 129
Síntesis de derivados de fluoroquinolona vía reacciones de multicomponentes
(Universidad Michoacana de San Nicolás de Hidalgo, 2020-10)
In the present work, the synthesis of hybrid fluoroquinolone-tetrazole molecules via Ugi-azide reaction is described. These molecules, which have not been reported in the literature and represent novel structures, are ...
Soportes nanoestructurados de PVA funcionalizados con un organocatalizador base pirrolilquinona-tetrazol
(Universidad Michoacana de San Nicolás de Hidalgo, 2019-05)
Some active organic molecules are efficient catalysts in selective oxidation reactions of organic compounds, reactions that have been a challenge in chemical synthesis. Organocatalysis has focused on the new efficient ...
Different effects on rat arterial pressure and heart rate when losartan is injected into the third or fourth ventricle
(1994-01-01)
Cardiovascular responses to central losartan (LOS), a non-peptide angiotensin II (ANG II) receptor antagonist, were investigated by comparing the effects of LOS injection into the 3rd and 4th cerebral ventricles (3rdV, ...
Effects of intracerebroventricular injections of losartan or PD123319 on arterial pressure and heart rate of sodium replete and sodium deplete rats
(1996-10-08)
Angiotensin II (Ang II) non-peptide antagonists were injected i.c.v. (6.25-200 nmol, n = 5-8 rats/group): In sodium replete rats, losartan (AT1 receptor antagonist) induced an increase in mean arterial pressure (MAP) and ...
Different effects on rat arterial pressure and heart rate when losartan is injected into the third or fourth ventricle
(1994-01-01)
Cardiovascular responses to central losartan (LOS), a non-peptide angiotensin II (ANG II) receptor antagonist, were investigated by comparing the effects of LOS injection into the 3rd and 4th cerebral ventricles (3rdV, ...
Effects of intracerebroventricular injections of losartan or PD123319 on arterial pressure and heart rate of sodium replete and sodium deplete rats
(1996-10-08)
Angiotensin II (Ang II) non-peptide antagonists were injected i.c.v. (6.25-200 nmol, n = 5-8 rats/group): In sodium replete rats, losartan (AT1 receptor antagonist) induced an increase in mean arterial pressure (MAP) and ...